Developing a universal flu vaccine to provide long-lasting immunity.
Collaborative Influenza Vaccine Innovation Centers (CIVICs) Component A: Vaccine Center
This study is looking for ways to make new flu vaccines that can protect you better and longer against different types of the flu, and if you join, you might help test these promising vaccines to see how well they work and if they're safe.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10668920 on NIH RePORTER |
What this research studies
This research focuses on creating and testing new types of influenza vaccines that can offer broad and lasting protection against various strains of the flu virus. The approach involves innovative designs and delivery methods to enhance the immune response in patients. By evaluating these candidate vaccines, the research aims to identify effective solutions that could potentially reduce the incidence of influenza and its complications. Patients may have the opportunity to participate in trials that assess the safety and efficacy of these new vaccines.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals who are at risk for influenza, such as the elderly, young children, and those with compromised immune systems.
Not a fit: Patients who are not at risk for influenza or those who have already received a flu vaccine may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a universal flu vaccine that protects against multiple strains of the virus, reducing the burden of influenza on patients.
How similar studies have performed: Other research has shown promise in developing innovative vaccines, but this approach aims to create a novel universal flu vaccine that has not yet been fully realized.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Moody, Tony — Duke University
- Study coordinator: Moody, Tony
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.